PLASMA LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY AND PLASMA-LIPOPROTEIN COMPOSITION AND CONCENTRATIONS IN KWASHIORKOR

Plasma lecithin-cholesterol acyltransferase (LCAT) activity, lipoprotein composition, and lipoprotein concentrations were measured in 21 children with kwashiorkor before (day 1), during (day 10), and after treatment (day 30). Day 1 LCAT activity (78.2-mu-mol.L-1.h-1) was decreased with respect to day 10 (139.2-mu-mol.L-1.h-1, P < 0.001) and day 30 (108.0-mu-mol.L-1.h-1, P = 0.08). Plasma total cholesterol (TC), cholesterol ester (CE), and lipoprotein CEs (VLDL, IDL, LDL, and HDL) were reduced relative to days 10 and 30 (P < 0.001). Before treatment HDL composition was abnormal. On days 1, 10, and 30, the respective mean HDL-apolipoprotein A-I (apo A-I) concentrations were 23.33, 39.66, and 36.08-mu-mol/L. LDL-apo B concentrations were 0.40, 0.68, and 0.56-mu-mol/L (P < 0.01, days 10 and 30 vs day 1). LDL particles on day 1 were decreased in number, depleted of CE, and laden with triacylglycerol and surface lipids. LCAT activity on day 1 correlated with LDL-CE linoleate (P < 0.05, r = 0.48). Reduced plasma LCAT activity is an important factor related to abnormalities in lipoprotein composition and concentrations.